CME Group (NASDAQ:CME) and S&P Global (NYSE:SPGI) were reportedly mulling a sale of their joint venture, OSTTRA, which offers post-trade solutions in the foreign exchange and derivatives markets.
The firms are working with advisers to search for buyers for the joint venture, Bloomberg reported, citing people familiar with the matter.
The joint venture might be valued between $2 billion – $4 billion, including debt, the report added.
OSTTRA was launched by CME and IHS Markit in 2021. The joint venture, at the time, incorporated the former’s optimization businesses –Traiana, TriOptima, and Reset, and the latter’s MarkitSERV. In 2022, SPGI had acquired IHS Markit.
The talks regarding the sale are still ongoing, the report said.
Shares in SPGI were down 0.2%, while CME fell 0.1%.
